Repository logo
  • Communities & Collections
  • All of DSpace
  • English
  • Español
  • Português do Brasil
  • Log In
    New user? Click here to register. Have you forgotten your password?
  • English
  • Español
  • Português do Brasil
  • Log In
    New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Vidal, Roberto"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    Norovirus vaccines under development
    (Elsevier, 2017) Lucero, Yalda; Vidal, Roberto; O'Ryan, Miguel
    Noroviruses (NoVs) are one of the leading causes of acute gastroenteritis, including both outbreaks and endemic infections. The development of preventive strategies, including vaccines, for the most susceptible groups (children <5years of age, the elderly and individuals suffering crowding, such as military personnel and travelers) is desirable. However, NoV vaccine development has faced many difficulties, including genetic/antigenic diversity, limited knowledge on NoV immunology and viral cycle, lack of a permissive cell line for cultivation and lack of a widely available and successful animal model. Vaccine candidates rely on inoculation of virus-like particles (VLPs) formed by the main capsid protein VP1, subviral particles made from the protruding domain of VP1 (P-particles) or viral vectors with a NoV capsid gene insert produced by bioengineering technologies. Polivalent vaccines including multiple NoV genotypes and/or other viruses acquired by the enteric route have been developed. A VLP vaccine candidate has reached phase II clinical trials and several others are in pre-clinical stages of development. In this article we discuss the main challenges facing the development of a NoV vaccine and the current status of prevailing candidates.

Santiago

Av. La Plaza Nº 680, Las Condes

Concepción

Ainavillo Nº 456, Concepción

Logo Universidad del Desarrollo

Implementado por OpenGeek Services